Tony Mok

Chinese University of Hong Kong

Papers

3

Total Citations

36

H-Index

2

About

Dr. Tony Mok is a leading interventional pulmonologist whose research focuses on minimally invasive, parenchyma-sparing techniques for lung cancer diagnosis and treatment. His work is particularly vital in an era of rising multifocal lung cancers and an aging patient population often unfit for traditional surgery. Dr. Mok’s major contributions center on advancing transbronchial and endobronchial therapies, including the use of robotic-assisted and electromagnetic navigation bronchoscopy. These technologies allow for precise localization and ablation of early-stage or premalignant lung lesions, a need amplified by the widespread adoption of low-dose CT screening. His most cited work, “Transbronchial Techniques for Lung Cancer Treatment: Where Are We Now?” (2023, 22 citations), provides a critical overview of this rapidly evolving field, while his 2024 review on endobronchial therapies (12 citations) outlines the current status and future directions. Dr. Mok’s research is instrumental in shaping a new standard of care, offering effective, localized treatment options that preserve lung function and improve patient outcomes.

Research Focus

Key Achievements

2
H-Index
3
Papers
36
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Transbronchial Techniques for Lung Cancer Treatment: Where Are We Now?
22 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Chinese University of Hong Kong

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago